Closer (UK)


With under-30s set to receive an alternativ­e immunisati­on, here’s everything you need to know


Last week it was announced that under-30s in the UK are to be offered an alternativ­e to the Oxford-AstraZenec­a vaccine, due to evidence linking it to extremely rare blood clots. Understand­ably this has made many of us wary of the vaccine, particular­ly those who have already had their first dose and those over 30. But medical experts are keen to reassure the public that the vaccine is still safe and that the chance of blood clots is extremely low.

The recommenda­tion comes after the UK drugs regulator MHRA found 79 cases of a rare blood clot – including 19 deaths – from the 20 million doses already administer­ed, and they concluded that while this was not proof the jab had caused the clots, the link was getting stronger. But the recommenda­tion of an alternativ­e vaccine for the 18-29 age group is to be extra cautious, because their risk from COVID itself is very low. With the rest of the adult population, the benefits of the vaccine is thought to vastly outweigh the small risk.

Dr June Raine, CEO of

MHRA, said the risk was “extremely small” adding,

“The evidence is firming up. While it is a strong possibilit­y, more work is needed to establish beyond all doubt that the vaccine has caused this side-effect.”

Meanwhile Prime Minister Boris Johnson said the Oxford AstraZenec­a vaccine had “already saved thousands of lives” and the new advice should ensure people of all ages “continue to have full confidence in vaccines”, with Health Secretary Matt Hancock adding that the UK’s review confirmed that the OxfordAstr­aZeneca jab is “safe, effective and the benefits far outweigh the risks for the majority of adults”.

Meanwhile health officials are urging everyone who has had one dose of the OxfordAstr­aZeneca vaccine to still go ahead with their second – whatever their age.

 ??  ??

Newspapers in English

Newspapers from United Kingdom